title: Myostatin depletion: a therapy for Ehlers-Danlos syndrome?
authors.forename: Paolo
authors.initials: P
authors.lastname: Prontera
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Belcastro
authors.forename: Paolo
authors.initials: P
authors.lastname: Calabresi
authors.forename: Emilio
authors.initials: E
authors.lastname: Donti
mesh_terms: D000328:Adult; D024061:Collagen Type III / Q000235:genetics; D024062:Collagen Type V / Q000378:metabolism; D004535:Ehlers-Danlos Syndrome / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007866:Leg / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D018482:Muscle, Skeletal / Q000473:pathology; D055435:Myostatin / Q000235:genetics*
chemical_list: C439971:COL3A1 protein, human; D024061:Collagen Type III; D024062:Collagen Type V; C525911:MSTN protein, human; D055435:Myostatin